Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Beigene Ltd       

BEIGENE LTD

 SummaryNewsRatingsCalendarCompany 
Company
BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib... 
Sector
Biotechnology & Medical Research
Calendar
09/18 | 11:20pmPresentation
More about the company
Surperformance© ratings of Beigene Ltd
Trading Rating : Investor Rating :
More Ratings
Latest news on BEIGENE LTD
09/16GLANCY PRONGAY & MURRAY LLP : Continues Its Investigation on Behalf of BeiGene, ..
BU
09/16Law Offices of Howard G. Smith Continues Its Investigation on Behalf of BeiGe..
BU
09/13BRAGAR EAGEL & SQUIRE, P.C. IS INVES : BGNE) on Behalf of BeiGene Stockholders a..
BU
09/13GLANCY PRONGAY & MURRAY LLP : Announces Investigation on Behalf of BeiGene, Ltd...
BU
09/12Law Offices of Howard G. Smith Announces Investigation on Behalf of BeiGene, ..
BU
09/12INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claim..
BU
09/12Investigation of BeiGene Announced by Holzer & Holzer, LLC
BU
09/12BEIGENE : Announces Clinical Data to Be Presented at the Annual Meeting of the C..
AQ
09/11INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
09/11Rosen Law Firm Announces Investigation of Securities Claims Against BeiGene, ..
BU
More news
Sector news : Bio Therapeutic Drugs
09/16A Plan to Fight Hep C -- WSJ
DJ
09/03Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
RE
08/29GLOBAL MARKETS LIVE : Dell, United Airlines, UBS, Apple…
08/28U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight
RE
08/28US Judge Mostly Sets Aside Jury Ruling on Repatha Patents -Reuters
DJ
More sector news : Bio Therapeutic Drugs
Chart BEIGENE LTD
Duration : Period :
Beigene Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
John V. Oyler Chairman & Chief Executive Officer
Xiao Bin Wu President
Maggie Liu Head-Operations
Howard Liang Chief Financial & Strategy Officer
Jane E Huang Chief Medical Officer-Hematology
Sector and Competitors
1st jan.Capitalization (M$)
BEIGENE LTD8 063
GILEAD SCIENCES5.79%83 801
VERTEX PHARMACEUTICALS6.21%45 238
REGENERON PHARMACEUTICALS-22.86%31 527
GENMAB27.73%13 120
NEUROCRINE BIOSCIENCES, INC.42.01%9 287